Holen Sie sich die Stockscreener-App
1.635
12.10%
-0.225
Finanzdaten der Phio Pharmaceuticals Corp-Aktie (PHIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 0.231 | - | - |
Operating Expenses
|
23.34%
2.309
|
1.872 | 1.674 | 1.59 | 1.914 |
| Operating Income/Loss |
23.34%
-2.309
|
-1.872 | -1.674 | -1.59 | -1.914 |
| Nonoperating Income/Loss |
750.00%
0.143
|
-0.022 | - | 0.066 | 0.068 |
| Income/Loss From Continuing Operations Before Tax |
22.44%
-2.166
|
-1.769 | 5.755 | -1.524 | -1.846 |
| Income/Loss From Continuing Operations After Tax |
22.44%
-2.166
|
-1.769 | -1.626 | -1.524 | -1.846 |
|
Net Income/Loss
|
22.44%
-2.166
|
-1.769 | -1.626 | -1.524 | -1.846 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
11.32%
4.7949
|
4.3073 | 0.1166 | 0.99 | 0.5102 |
| Diluted Average Shares |
11.32%
4.7949
|
4.3073 | 0.1166 | 0.99 | 0.5102 |
| Basic Earnings Per Share |
9.76%
-0.45
|
-0.41 | -0.85 | -1.54 | -3.62 |
| Diluted Earnings Per Share |
9.76%
-0.45
|
-0.41 | -0.85 | -1.54 | -3.62 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.11%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):